Archive for the ‘Drug Czar’ Category

Medical Cannabis – defacto policy in USA

February 27, 2009

Medical cannabis card in Marin County, Califor...Image via Wikipedia

DEA administrator confirms Obama’s wish to ‘cease medpot raids’. This is highly significant change in policy direction from the FED’s and is consistent with Admininstrations appointment of the Chief of Police of Seattle (Christchurch Sister City) as the new administration Drug Czar. /Blair

Speaking at a press conference with DEA administrator Michelle Leonhart, Attorney General Eric Holder declared that ending medical marijuana raids “is now American policy.”

A reporter asked, “shortly after the inauguration there were raids on California medical marijuana dispensaries…do you expect these to continue?”, noting

WAMP supporters march to Los Angeles City HallImage via Wikipedia

that the President had promised to end the raids in the campaign.

Holder responded, “What the President said during the campaign…is consistent with what we will be doing here in law enforcement. He was my boss in the campaign….He is my boss now. What he said in the campaign is now American policy.” !!!

The question appears about 25 minutes into the press conference, which was devoted to an operation against the Mexican Sinaloa drug cartel.

http://www.c-span.org/Watch/watch.aspx?MediaId=HP-A-15821

Blair Anderson
http://mildgreens.blogspot.com

Related articles by Zemanta

Jim says… reclassification noted

February 20, 2008

“They expressed admiration for our evidence-based policies and for our reclassification processes.” – Jim Anderton commenting on his meetings with two of the distinguished keynote (2008 Parliamentary Drug Policy Roundtable) speakers: Professor David Nutt, [and] Associate Professor Alison Ritter.

Every one reports to Czar Jim ‘or else’.
No wonder Jim was uncomfortable knowing I might be there!

(caution: links to Anderton’s Progressive’s Press Release may cause temporary insanity)

Blair Anderson
http://mildgreens.blogspot.com

Here is how to talk about drugs! [British Medical Association]

November 9, 2007
Boosting your brainpower:
Ethical aspects of cognitive enhancements


There may be a few readers of this blog who will remember the 2000 MildGreen Millennium Initiative for Cognitive Liberty.


There has been a maturation in the global dialogue about ethnobotanicals, entheogens, off-label pharmaceuticals and emerging new psycho stimulants.


This highlights the ethical inadequacy of and corresponding marginalisation of Kiwi Drug Czar and MP (Wigram) Hon Jim Anderton’s propaganda machine along with his Ministry of Health’s parlous 2006 drug policy’ consultation.


Read on, but be aware, this is both a precursor blog entry and a weapon of mass emancipation. Enjoy. The underlines are courtesy of your blogmiester, /Blair)

The key aim of this paper is to facilitate informed debate amongst doctors, scientists, policy-makers, and members of the public about the future development and use of cognitive enhancements. Providing the facts, information and some of the arguments it signals the beginning of a debate about how, as a society, we should consider and respond to the opportunities and challenges presented by cognitive enhancements. A discussion paper from the *BMA / November 2007


Executive summary

  • People have long been interested in improving their brainpower. Developments in medicine and pharmacy could provide new ways of doing that but because they raise ethical issues that have not been widely discussed, there is a need for public debate about them. In Part One, this paper sets out some definitions and a framework for debate.
  • Drugs and medical interventions designed as therapy for people with diagnosed problems are likely to be sought in future by healthy people to “improve” on nature. It is important to distinguish, however, between what is possible now or will be in the near future and more abstract speculation about longer-term developments. In Part Two, the document examines the evidence (or lack of it) for different methods of enhancement, including nutritional supplements, pharmaceuticals and surgery.
  • People may not only want to choose enhancement for themselves but also for their children. The possibilities and limitations of genetic manipulation and selection as a means of enhancing future people are also covered in Part Two.
  • Individuals have always been able to try and improve their own or their children’s intellectual abilities through study and effort. The possibility of shortcutting that process and lessening the effort required by using nutrition, drugs or medical techniques is more controversial. Part Three considers why this might be.
  • It looks at the speculation about how the new technologies might bring about either positive or negative social and cultural changes, affecting not only individuals but the fabric of society. Arguments that have been put forward by those for and against such a change are briefly summarised.
  • One of the main arguments concerns interconnectedness. For the purposes of discussion, the paper looks at cognitive functioning as if it could be isolated from other parts of a person’s life. In reality the potential risks or benefits of cognitive enhancement for other aspects of individuals’ personality, such as emotional stability and creativity, cannot be isolated. People are also interconnected in a social sense, so that choices made by some are likely to impact on others and possibly on society at large. This is highlighted throughout the paper and discussed in detail in Part Three where some suggestions are considered about how a balance might be attained between personal liberty and responsibility to the community.
  • Why we may have quite different moral views about different methods, even though they all have the same goal, is also discussed in Part Three.
  • Almost anything we try may have some unforeseen side-effects or carry some risks. In order to decide whether change should be regulated, the scope and limits of what individuals should be able to choose for themselves or for other people also need to be discussed. Part Four sets out the arguments for and against limiting choice and considers how regulation, if needed, might be implemented.
  • The main questions arising from the paper are summarised in Part Five. The BMA does not have policy or recommendations to put forward on these issues but would welcome informed public debate about how, as a society, we should respond to these developments .

* The British Medical Association – the professional association for doctors. With over 139,000 members, representing practising doctors in the UK and overseas and medical students, the BMA is the voice of the profession and students.

Blair Anderson ‹(•¿•)›

Social Ecologist ‘at large’
http://mildgreens.blogspot.com/
http://blairformayor.blogspot.com/
http://blair4mayor.com/

ph (643) 389 4065 cell 027 265 7219

Drug classification beset by confusion [UK]

November 1, 2007

[ 01/11/2007- The Guardian ] In looking at the reclassification of cannabis in 2004 you claim “Ministers are coy about the success of their policy” in reducing use (Leaders, October 29). Let us be careful about spurious associations. In fact, cannabis use among school children was broadly stable according to a 2001-03 English school survey and has since declined. For adults, according to the British Crime Survey, cannabis use peaked in 2002-03 and has subsequently declined. The classification of a drug has little bearing on its prevalence, as the figures demonstrate.

There is no evidence here or internationally that the particular classification of a controlled drug acts as a deterrent to use.

Economic, social and cultural factors, along with availability, are the stronger influences. (the decline commenced prior to the Class B -> C UK reclassification, but may be in part a response to London Met. Det Chief Super, Eddie Ellison’s ‘Policing management’ call to deal with cannabis by ‘means other than arrest’ /Blair )

There is a general confusion surrounding the purpose and function of the classification system. In the UK it currently provides a steer to national and local policing priorities , prosecution and sentencing practice. (same as in NZ)

Given the recent history of the debate about cannabis, we consider that a review of the entire basis of the classification system and the process for making decisions on drug classifications is overdue. We have made this point in our recent submission to the government consultation about its revised drug strategy. In particular, the opportunity should be taken to review the role of politicians in making decisions about the classification of controlled drugs – for example, to explore whether there are models that place decision-making outside of ministerial influence , as has happened with national statistics, the new Independent Safeguarding Authority and interest rates.

Roger Howard Chief executive, UK Drug Policy Commission

I think this explains why the [dis] Hon “drug Czar” Jim Anderton (and his simpering pathetic staff who cant resist embellishing a simple request for a meeting into a ‘terrorising threat’ ) chooses to ignore evidence based drug policy.

Blair Anderson ‹(•¿•)›

Social Ecologist ‘at large’
http://mildgreens.blogspot.com
http://blairformayor.blogspot.com
http://blair4mayor.com

ph (643) 389 4065 cell 027 265 7219

New Drug Policy launched – pressure kept on

March 15, 2007

pressure… bah humbug!

Launch of the National Drug Policy 2007 – 2012, Grand Hall, Parliament

http://www.beehive.govt.nz/speech/new+drug+policy+launched+-+pressure+kept

And all this is the result of a ‘due process’ found to be gravely wanting.
There were strong opinions within the EACD but the predominance of stake hold interests in status quo saw the health concerns and applied everything that has never been shown to work.

Some on the EACD seem to think, if you bang your head against the wall long enough it will stop hurting.

Blair Anderson
http://mildgreens.blogspot.com